Huatai Biopharm Inc., Deyang, China – FDA Inspections

Inspection records and compliance data for Huatai Biopharm Inc. in Deyang. 5 FDA inspections on record, 1 Form 483, last inspected September 19, 2025.

Company Profile

This profile covers Huatai Biopharm Inc. based in Deyang, China.

FDA Inspection History

FDA inspections: 5
OAI: 0
VAI: 4
NAI: 0
Unclassified: 1
Form 483s: 1
Warning letters: 0

First inspected September 10, 2009. Last inspected September 19, 2025.

FDA inspections (5)

Date	Result	FDA center(s)	Insp. #
September 19, 2025	Not classified	Human Drugs	1288714
May 23, 2019	VAI	Human Drugs · Drug Quality Assurance	1144990
June 17, 2016	VAI	Human Drugs · Drug Quality Assurance	979665
April 24, 2014	VAI	Human Drugs · Drug Quality Assurance	879315
September 10, 2009	VAI	Human Drugs · Drug Quality Assurance	617852

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Zhejiang Chiral Medicine Chemicals Co., Ltd.

Zhejiang Starry Pharmaceutical Co. Ltd.

Hubei Enoray Biopharmaceutical Co., Ltd.

Sinobest Cosmeceutical Co., Ltd.

Shanghai Soho-Yiming Pharmaceuticals Co., Ltd.

Chongqing Carelife Pharmaceutical Co., Ltd.

Shandong Keyuan Pharmaceutical Co., Ltd.

Shandong Apeloa Tospo Pharmaceutical Co., Ltd.

Zhejiang Haizhou Pharmaceutical Co., Ltd.

Tianjin Weijie Pharmaceutical Co., Ltd.